Significant reduction in circulation complement (C3) was found in 43 rheumatoid arthritis patients treated with PNS for 28 days, and which was associated with improved clinical symptoms such as joint swelling index when compared to the control subjects (50). This evidence concerns the gene C3 and rheumatoid arthritis.